Cargando…
Rutaecarpine Increases Anticancer Drug Sensitivity in Drug-Resistant Cells through MARCH8-Dependent ABCB1 Degradation
The overexpression of adenosine triphosphate (ATP)-binding cassette (ABC) subfamily B member 1 (ABCB1; P-glycoprotein; MDR1) in some types of cancer cells is one of the mechanisms responsible for the development of multidrug resistance (MDR), which leads to the failure of chemotherapy. Therefore, it...
Autores principales: | Zou, Tingting, Zeng, Cheng, Qu, Junyan, Yan, Xiaohua, Lin, Zhenghong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466742/ https://www.ncbi.nlm.nih.gov/pubmed/34572328 http://dx.doi.org/10.3390/biomedicines9091143 |
Ejemplares similares
-
Evodiamine and Rutaecarpine as Potential Anticancer Compounds: A Combined Computational Study
por: Liu, Jingli, et al.
Publicado: (2022) -
Progress in the Studies on Rutaecarpine
por: Lee, Seung Ho, et al.
Publicado: (2008) -
Sapitinib Reverses Anticancer Drug Resistance in Colon Cancer Cells Overexpressing the ABCB1 Transporter
por: Gao, Hai-Ling, et al.
Publicado: (2020) -
Time effect of rutaecarpine on caffeine pharmacokinetics in rats
por: Estari, Rohit Kumar, et al.
Publicado: (2021) -
Promising derivatives of rutaecarpine with diverse pharmacological activities
por: Li, Deping, et al.
Publicado: (2023)